Journal
JOURNAL OF APPLIED MICROBIOLOGY
Volume 106, Issue 4, Pages 1370-1377Publisher
WILEY
DOI: 10.1111/j.1365-2672.2008.04105.x
Keywords
antimicrobial protein; Bacillus coagulans; isolation; probiotic
Categories
Funding
- NIH [NCCAM NIH R21AT002897-01]
- Sabinsa Corporation (Piscataway, NJ)
Ask authors/readers for more resources
To characterize the antimicrobial protein produced by Bacillus coagulans used in the probiotic dietary supplement (Lactospore((R)) Probiotic, Sabinsa Corp., Piscataway, NJ, USA). Bacillus coagulans ATCC 7050 was grown at 37 degrees C for 18 h. The cell free supernatant was concentrated 10-fold (lactosporin preparation, LP). The antimicrobial activity of LP was confirmed against Micrococcus luteus ATCC 10420 in a well diffusion assay. The proteinaceous nature of LP was determined following exposure to different enzymes. The activity of LP was pH-dependent but stable to heat. The isoelectric point of LP was determined to be 3.5-4.0. PCR analyses showed no similarity between lactosporin and known antimicrobial proteins produced by the Bacillus spp. Lactosporin is a novel antimicrobial protein. Initial characterization indicates that it may fall outside of the conventional classification of class I and II bacteriocins. Loss of activity after exposure to a number of proteolytic enzymes and lipase suggest that lactosporin may posses a lipid moiety which contributes to its inhibitory activity. The unique characteristics of lactosporin, including its antimicrobial activity against pathogenic micro-organisms, indicate that it may have potential for application in foods and personal care products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available